Chemical Structure (Bumetanide 01)
Bumetanide Tablet
Product Images NDC 51672-4224
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 51672-4224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (0.5 mg Tablet Bottle Label)
Principal Display Panel (1 mg Tablet Bottle Label)
Dispense In a tight, light-resistant container. This text appears to be the label of medication called Bumetanide, USP, which is available in the form of tablets. It contains 40mg of Bumetanide per tablet. The usual dosage and prescribing information are not visible. The medication is manufactured by Taro Pharmaceutical Industries Ltd, located in Halfa, Israel. The label also provides information about the storage temperature (20° to 26°C or 68° to 77°F) and the batch number and expiration date for the specific batch mentioned in the text. The label advises keeping the medication out of the reach of children and indicates that it is distributed by Taro Pharmaceuticals USA, Inc., based in Hawthorne, NY.*
Principal Display Panel (2 mg Tablet Bottle Label)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
